PAIGE SEAVEY: Open Payments
NPI 1154042794 · RANDOLPH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 32 payments from 11 companies in 2025. Trend: 2023 $194 · 2024 $436 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $127 |
| AstraZeneca Pharmaceuticals LP | 5 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $63 |
| PFIZER INC. | 4 | $60 |
| Lilly USA, LLC | 3 | $55 |
| Exact Sciences Corporation | 2 | $52 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: REXULTI, MOUNJARO, Cologuard Collection Kit, Auvelity, Ozempic, FARXIGA, QULIPTA, PREVNAR 20.
Industry payments across NJ — which companies pay providers there.
